XML 18 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Noncontrolling Interest
Beginning Balance at Dec. 31, 2020 [1] $ 30,611 $ 164 $ 417,855 $ (387,408) $ 0
Beginning Balance, Shares at Dec. 31, 2020 [1]   164,063,787      
Net loss attributable to Alignment Healthcare, Inc. (147,452) $ 0 0 (147,452) 0
Noncontrolling interest attributable to subsidiary 15 0 0 0 15
Issuance of common stock, net of issuance costs 361,589 $ 22 361,567 0 0
Issuance of common stock, net of issuance costs, Shares   21,700,000      
Issuance of common stock to third-party business partners 6,480 $ 1 6,479 0 0
Issuance of common stock to third-party business partners, Shares   573,782      
Issuance of common stock to stock appreication rights holders 11,510 $ 1 11,509 0 0
Issuance of common stock to stock appreication rights holders, Shares   936,213      
Forfeitures, shares   (22,946)      
Equity-based compensation 63,796 $ 0 63,796 0 0
Equity repurchase (1,474) 0 1,474 0 0
Ending Balance at Sep. 30, 2021 325,075 $ 188 859,732 (534,860) 15
Ending Balance, Shares at Sep. 30, 2021   187,250,836      
Beginning Balance at Jun. 30, 2021 340,380 $ 188 829,221 (489,044) 15
Beginning Balance, Shares at Jun. 30, 2021   187,273,782      
Net loss attributable to Alignment Healthcare, Inc. (45,816) $ 0 0 (45,816) 0
Forfeitures, shares   (22,946)      
Equity-based compensation 30,511 $ 0 30,511 0 0
Ending Balance at Sep. 30, 2021 325,075 $ 188 859,732 (534,860) 15
Ending Balance, Shares at Sep. 30, 2021   187,250,836      
Beginning Balance at Dec. 31, 2021 $ 306,055 $ 187 888,547 (582,694) 15
Beginning Balance, Shares at Dec. 31, 2021 187,193,613 187,193,613      
Net loss attributable to Alignment Healthcare, Inc. $ (92,644) $ 0 0 (92,644) 0
Issuance of common stock upon vesting of restricted stock units   433,440      
Forfeitures 0 $ 0 0 0 0
Forfeitures, shares   (363,077)      
Equity-based compensation 58,833 $ 0 58,833 0 0
Repurchase of noncontrolling interest attributable to subsidiary (100) 0 (85) 0 (15)
Ending Balance at Sep. 30, 2022 $ 272,144 $ 187 947,295 (675,338) 0
Ending Balance, Shares at Sep. 30, 2022 187,263,976 187,263,976      
Beginning Balance at Jun. 30, 2022 $ 293,704 $ 187 928,608 (635,091) 0
Beginning Balance, Shares at Jun. 30, 2022   187,271,311      
Net loss attributable to Alignment Healthcare, Inc. (40,247) $ 0 0 (40,247) 0
Issuance of common stock upon vesting of restricted stock units   956      
Forfeitures 0 $ 0 0 0 0
Forfeitures, shares   (8,291)      
Equity-based compensation 18,687 $ 0 18,687 0 0
Ending Balance at Sep. 30, 2022 $ 272,144 $ 187 $ 947,295 $ (675,338) $ 0
Ending Balance, Shares at Sep. 30, 2022 187,263,976 187,263,976      
[1] The consolidated balances as of December 31, 2020 were derived from the audited consolidated financial statements as of that date and were retroactively adjusted, including shares and per share amounts, as a result of the Reorganization. See Note 1 to the condensed consolidated financial statements for additional details.